| OAB0303 | Dual therapy based on DRVr plus 3TC in HIV-1 naïve patients: global 48 week results from ANDES Study | Oral abstract session with live Q&A | ART in acute, first- and second-line therapies |
| PESAA06 | Dual role of HIV-1 Envelope Signal Peptide in immune evasion | Poster exhibition | HIV transmission and dissemination |
| EPD284 | Dual oral therapy in France (PROBI study): the acceptability of switch among HIV patients and physicians | E-poster | Behavioural factors impacting acceptability and uptake of an HIV vaccine |
| EPA069 | Dual antiretroviral loaded nanoparticles for long-acting suppressive HIV therapy | E-poster | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| PESUB17 | DTG associated weight gain: real or perceived? Real world experiences from Zimbabwe | Poster exhibition | Weight gain |
| EPB178 | Drug-drug interactions between antiretrovirals and remdesivir | E-poster | Drug interactions |
| EPB244 | Drug resistance in children with HIV in the Democratic Republic of Congo, Equatorial Guinea and Panama | E-poster | Resistance to ART |
| EPF072 | Drug enforcement remains a top barrier for people who inject drugs to access HIV and TB prevention, care, and treatment in Georgia, Kyrgyzstan, Moldova, Russia, Tajikistan, Ukraine, and Uzbekistan | E-poster | Human rights of people living with HIV and key populations |
| EPF044 | Drug decriminalization done right: a civil society platform | E-poster | Criminalization, incarceration and living in closed settings |
| EPE260 | Drone technology to facilitate access to medical supplies and commodities for maternal, child and HIV treatment in East and Southern Africa Region | E-poster | Approaches to supporting resilient health systems |